• Oropharyngeal cancer and human...

Treffer: Oropharyngeal cancer and human papillomavirus: a visualization based on bibliometric analysis and topic modeling.

Title:
Oropharyngeal cancer and human papillomavirus: a visualization based on bibliometric analysis and topic modeling.
Authors:
Liu Z; Department of Head and Neck Surgery, Cancer Hospital of China Medical University/Liaoning Cancer Hospital & Institute, Shenyang, China., Wang H; Department of Abdominal Osteomalacia Radiotherapy, Cancer hospital of China Medical University/Liaoning Cancer hospital and Institute, Shenyang, China.; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China., Xu Y; Department of Head and Neck Surgery, Cancer Hospital of China Medical University/Liaoning Cancer Hospital & Institute, Shenyang, China., Wei H; Department of Head and Neck Surgery, Cancer Hospital of China Medical University/Liaoning Cancer Hospital & Institute, Shenyang, China., Zhang Y; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China., Dong H; Department of Head and Neck Surgery, Cancer Hospital of China Medical University/Liaoning Cancer Hospital & Institute, Shenyang, China.
Source:
Frontiers in microbiology [Front Microbiol] 2024 May 29; Vol. 15, pp. 1387679. Date of Electronic Publication: 2024 May 29 (Print Publication: 2024).
Publication Type:
Journal Article; Systematic Review
Language:
English
Journal Info:
Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101548977 Publication Model: eCollection Cited Medium: Print ISSN: 1664-302X (Print) Linking ISSN: 1664302X NLM ISO Abbreviation: Front Microbiol Subsets: PubMed not MEDLINE
Imprint Name(s):
Original Publication: Lausanne : Frontiers Research Foundation
References:
CA Cancer J Clin. 2023 Mar;73(2):164-197. (PMID: 36305841)
J Clin Oncol. 2011 Nov 10;29(32):4294-301. (PMID: 21969503)
Cancer Treat Rev. 2022 Nov;110:102439. (PMID: 36126367)
Radiographics. 2019 Nov-Dec;39(7):2055-2068. (PMID: 31603733)
Lancet. 2019 Aug 10;394(10197):497-509. (PMID: 31255301)
Head Neck. 2015 Mar;37(3):381-5. (PMID: 24431059)
JAMA Otolaryngol Head Neck Surg. 2020 Jul 1;146(7):656-664. (PMID: 32379293)
Pathogens. 2023 Jan 18;12(2):. (PMID: 36839432)
N Engl J Med. 2016 Nov 10;375(19):1856-1867. (PMID: 27718784)
Ann Oncol. 2019 Feb 1;30(2):297-302. (PMID: 30481287)
Clin Cancer Res. 2023 Feb 1;29(3):560-570. (PMID: 36455147)
J Clin Oncol. 2017 Feb 10;35(5):490-497. (PMID: 28029303)
Cancers (Basel). 2024 Mar 15;16(6):. (PMID: 38539498)
J Clin Oncol. 2023 Jun 10;41(17):3081-3088. (PMID: 37285653)
J Clin Oncol. 2019 Oct 10;37(29):2661-2669. (PMID: 31411949)
Cancer. 2018 Feb 15;124(4):717-726. (PMID: 29243245)
Head Neck. 2020 Dec;42(12):3479-3489. (PMID: 32866313)
Gynecol Oncol. 2017 Jul;146(1):196-204. (PMID: 28442134)
Head Neck. 2021 Nov;43(11):3681-3696. (PMID: 34323332)
JAMA Otolaryngol Head Neck Surg. 2017 Jun 1;143(6):580-588. (PMID: 28358930)
Laryngoscope. 2013 Jan;123(1):152-7. (PMID: 23008061)
Int J Mol Sci. 2024 Feb 28;25(5):. (PMID: 38474047)
J Infect Dis. 2016 Jun 15;213(12):1893-6. (PMID: 26908748)
J Exp Clin Cancer Res. 2022 Sep 20;41(1):279. (PMID: 36123711)
EBioMedicine. 2019 Oct;48:169-177. (PMID: 31521609)
J Oral Pathol Med. 2020 Oct;49(9):886-896. (PMID: 32516834)
Viruses. 2021 Jul 09;13(7):. (PMID: 34372532)
Eur J Immunol. 2017 Jun;47(6):946-953. (PMID: 28475283)
J Clin Oncol. 2018 Jan 20;36(3):262-267. (PMID: 29182497)
JAMA Otolaryngol Head Neck Surg. 2022 Feb 1;148(2):155-165. (PMID: 34913945)
Front Oncol. 2024 Mar 07;14:1333640. (PMID: 38515578)
Front Oncol. 2021 Aug 30;11:710286. (PMID: 34527583)
J Oral Pathol Med. 2021 Jan;50(1):47-51. (PMID: 32745295)
Nat Protoc. 2019 Oct;14(10):2986-3012. (PMID: 31548639)
J Intern Med. 2020 Feb;287(2):134-152. (PMID: 31733108)
Lancet. 2019 Jan 5;393(10166):40-50. (PMID: 30449625)
Otolaryngol Head Neck Surg. 2015 Nov;153(5):758-69. (PMID: 26124261)
Radiother Oncol. 2019 May;134:81-88. (PMID: 31005228)
Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1660-1667. (PMID: 31358520)
Oral Oncol. 2021 Nov;122:105566. (PMID: 34662771)
J Clin Oncol. 2019 Aug 1;37(22):1909-1918. (PMID: 31163012)
Lancet. 2019 Nov 23;394(10212):1915-1928. (PMID: 31679945)
J Clin Oncol. 2021 Mar 20;39(9):956-965. (PMID: 33507809)
Lancet Oncol. 2010 Aug;11(8):781-9. (PMID: 20451455)
Front Oncol. 2021 Oct 14;11:732166. (PMID: 34722273)
J Immunother. 2017 Feb/Mar;40(2):62-70. (PMID: 28166181)
Laryngoscope. 2018 Feb;128(2):403-411. (PMID: 28771728)
Ann Oncol. 2023 Dec;34(12):1175-1186. (PMID: 37879442)
JAMA Otolaryngol Head Neck Surg. 2013 Jan;139(1):43-8. (PMID: 23247974)
Hum Vaccin Immunother. 2019;15(7-8):1794-1802. (PMID: 30481108)
Cancer. 2018 Jun 1;124(11):2347-2354. (PMID: 29579339)
Nat Rev Clin Oncol. 2022 May;19(5):306-327. (PMID: 35105976)
Sci Rep. 2021 Aug 9;11(1):16134. (PMID: 34373557)
J Clin Oncol. 2009 Apr 20;27(12):1992-8. (PMID: 19289615)
Front Genet. 2022 May 27;13:820065. (PMID: 35692828)
Int J Cancer. 2017 Mar 1;140(5):1186-1198. (PMID: 27859245)
Future Sci OA. 2016 Jan 07;2(1):FSO88. (PMID: 28031938)
Lancet. 2019 Jan 12;393(10167):156-167. (PMID: 30509740)
Lancet Oncol. 2017 Jun;18(6):803-811. (PMID: 28434660)
JCI Insight. 2016 Oct 20;1(17):e89829. (PMID: 27777979)
Lancet. 2019 Jan 5;393(10166):51-60. (PMID: 30449623)
CA Cancer J Clin. 2017 Mar;67(2):93-99. (PMID: 28094848)
J Clin Oncol. 2014 Sep 20;32(27):2940-50. (PMID: 25154822)
Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1053-9. (PMID: 19577857)
JAMA Otolaryngol Head Neck Surg. 2016 Jul 1;142(7):691-7. (PMID: 27347780)
Georgian Med News. 2021 Jan;(310):29-35. (PMID: 33658405)
Oral Oncol. 2023 Dec;147:106610. (PMID: 37951118)
Oncoimmunology. 2018 Mar 15;7(5):e1424672. (PMID: 29721385)
PLoS One. 2013 Jul 17;8(7):e68329. (PMID: 23873171)
Head Neck. 2016 Apr;38(4):589-600. (PMID: 25488048)
Sci Data. 2023 Oct 12;10(1):694. (PMID: 37828063)
Prev Med. 2021 Mar;144:106399. (PMID: 33388322)
Contributed Indexing:
Keywords: HPV; bibliometric analysis; oropharyngeal cancer; topic modeling; treatment strategies
Entry Date(s):
Date Created: 20240626 Latest Revision: 20240627
Update Code:
20250114
PubMed Central ID:
PMC11197978
DOI:
10.3389/fmicb.2024.1387679
PMID:
38919494
Database:
MEDLINE

Weitere Informationen

Objectives: The incidence of oropharyngeal cancer (OPC) is increasing. This study used bibliometric analysis and topic modeling to explore the research trends and advancements in this disease over the past 10 years, providing valuable insights to guide future investigations.
Methods: 7,355 English articles from 2013 to 2022 were retrieved from the Web of Science Core Collection for bibliometric analysis. Topic modeling was applied to 1,681 articles from high-impact journals, followed by an assessment of topic significance ranking (TSR). Medical Subject Headings (MeSH) terms were extracted using R and Python, followed by an analysis of the terms associated with each topic and on an annual basis. Additionally, genes were extracted and the number of genes appearing each year and the newly emerged genes were counted.
Results: The bibliometric analysis suggested that the United States and several European countries hold pivotal positions in research. Current research is focused on refining treatments, staging and stratification. Topic modeling revealed 12 topics, emphasizing human papillomavirus (HPV) and side effect reduction. MeSH analysis revealed a growing emphasis on prognosis and quality of life. No new MeSH terms emerged after 2018, suggesting that the existing terms have covered most of the core concepts within the field of oropharyngeal cancers. Gene analysis identified TP53 and EGFR as the most extensively studied genes, with no novel genes discovered after 2019. However, CD69 and CXCL9 emerged as new genes of interest in 2019, reflecting recent research trends and directions.
Conclusion: HPV-positive oropharyngeal cancer research, particularly treatment de-escalation, has gained significant attention. However, there are still challenges in diagnosis and treatment that need to be addressed. In the future, more research will focus on this issue, indicating that this field still holds potential as a research hotspot.
(Copyright © 2024 Liu, Wang, Xu, Wei, Zhang and Dong.)

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.